Accepted at 5:34 a.m. Aug, 18, 2025 by Stapedius
Author: julian_stevenson
Co-authors: Stapedius
Related Note: 1676981882661
Rationale for change

Note that this card is near identical to 1676785107640, but with different. Maybe combine them. However, I believe both should include SGLT2i, so I will edit this one too, as I expect would be recommended by most cardiologists.

Text Text
Extra
Extra (Synced)
Empty field
Personal Notes
Empty field
Missed Questions
Empty field
eTG Complete
Talley & O'Connor
Empty field
Additional Resources
Empty field
Additional Resources (Synced)
Empty field
Source
Empty field
One by one
Empty field
Changed Tags
#Malleus_CM::#TO_BE_TAGGED #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Lisinopril::03_Indications #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Ramipril::03_Indications #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::01_Drugs_for_heart_failure::01_Aldosterone_antagonists::Spironolactone::03_Indications #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Fosinopril::03_Indications #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::05_Beta-blockers::Bisoprolol::03_Indications #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Captopril::03_Indications #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::05_Beta-blockers::Propranolol::03_Indications #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::01_Drugs_for_heart_failure::01_Aldosterone_antagonists::Finerenone::03_Indications #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Fozinopril::03_Indications #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::05_Beta-blockers::Atenolol::03_Indications #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::01_Drugs_for_heart_failure::01_Aldosterone_antagonists::Eplerenone::03_Indications #Malleus_CM::#Resources_by_Rotation::Internal_Medicine::General_Medicine #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::05_Beta-blockers::Metoprolol::03_Indications #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Trandolapril::03_Indications #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Perindopril::03_Indications #Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Cardiology #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::05_Beta-blockers::Labetalol::03_Indications #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Quinapril::03_Indications #Malleus_CM::#Resources_by_Rotation::Emergency #Malleus_CM::#Question_Banks::eMedici::4000-4999::4731 #Malleus_CM::#Subjects::Critical_Care::03_Circulation::03_Shock_&_Heart_Failure::Heart_Failure::10_Management #Malleus_CM::#Resources_by_Rotation::General_Practice #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Enalapril::03_Indications #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::05_Beta-blockers::Carvedilol::03_Indications #Malleus_CM::#Subjects::Cardiology::02_Heart_Failure::Heart_Failure::10_Management #Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::05_Beta-blockers::Nebivolol::03_Indications